Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Wright Medical Announces Fundamental Change With Respect to the 2.25% Cash Convertible Senior Notes due 2021 issued by Wright Medical Group N.V. and the 1.625% Cash Exchangeable Senior Notes due 2023 issued by Wright Medical Group, Inc. AMSTERDAM, The Netherlands, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Wright Medical today announced that in connection with the tender offer (the “Tender Offer”) and the mergers (the “Mergers”) pursuant to which Wright Medical Group N.V. (“WMG”) was acquired by Stryker Corporation, Stryker Unite, Ltd. (formerly Wright Medical Ltd.) succeeded to and assumed any an...
The independent financial analyst theScreener just slightly lowered the general evaluation of WRIGHT MEDICAL (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title confirms its rating of 3 out of 4 stars while its market behaviour remains unchanged and can be qualified as defensive. However, a marginally less favourable environment forces theScreener to downgrade slightly the title, which now shows an overall rating of Slightly Positive. As of the analysi...
Wright Medical Group N.V. Announces Update to Medicare Transitional Device Pass-Through Payment for AUGMENT® Regenerative Solutions Transitional Pass-Through Payment Reimburses Hospital Outpatient and Ambulatory Surgical Centers for Incremental Cost of AUGMENT in Hindfoot and Ankle Fusion Procedures Facilitates Medicare Beneficiary Access to AUGMENT by Removing Economic Barrier AMSTERDAM, The Netherlands, July 20, 2020 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that the Centers for Medicare & Medicaid Services (CMS) published an update to the reimburs...
Wright Medical Group N.V. Announces First Shoulder Arthroplasty Procedure Using BLUEPRINT™ Mixed Reality Technology Mayo Clinic Performs First-Ever Shoulder Procedure Utilizing 3-D, Holographic Views Displayed by Mixed Reality System AMSTERDAM, The Netherlands, July 15, 2020 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that the first shoulder arthroplasty procedure was performed using groundbreaking at Mayo Clinic’s campus in Rochester, Minnesota. Joaquin Sanchez-Sotelo, M.D., Ph.D, performed the procedure utilizing BLUEPRINT OR Visualization Mixed Real...
Wright Medical Group N.V. Announces Virtual Meeting Alternative to Physical Attendance at Extraordinary General Meeting of Shareholders and Change of Time and Location of Meeting Date of Meeting and Ability to Vote by Proxy Not Changed AMSTERDAM, April 08, 2020 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today provided notice that, for shareholders wishing to participate in person at its previously noticed Extraordinary General Meeting of Shareholders scheduled for April 24, 2020 (the “EGM”), Wright is providing such shareholders an alternative to physical attendance at...
A director at Wright Medical Group Nv sold/gave away 143,351 shares at 0.000USD and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Wright Medical Group N.V. Announces Definitive Agreement to be Acquired by Stryker Purchase Price of $30.75 Per Share in Cash; Total Enterprise Value of Approximately $5.4 Billion and Total Equity Value of Approximately $4.7 Billion Proposed Acquisition Brings Together Highly Complementary Product Portfolios and Customer Base AMSTERDAM, The Netherlands, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it has entered into a definitive agreement under which Stryker (NYSE: SYK) will acquire all of the issued and ...
Wright Medical Group N.V. to Host Third Quarter 2019 Earnings Conference Call Wednesday, November 6, 2019 at 3:30 p.m. Central / 4:30 p.m. Eastern AMSTERDAM, The Netherlands, Oct. 09, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it will host a conference call on Wednesday, November 6, 2019, at 3:30 p.m. Central Time to discuss the company’s operating results for its third quarter ended September 29, 2019. Operating results will be released at 3:05 p.m. Central Time that day. The live dial-in number for the call is (844) 295-9436 (U.S.) / (574...
Wright Medical Group N.V. Highlights Recent Innovations and Clinical Data at the American Orthopaedic Foot & Ankle Society (AOFAS) 2019 Annual Meeting Company to Showcase CARTIVA® Synthetic Cartilage Implant, PROstep™ Minimally Invasive Surgery System, Total Ankle Continuum of Care and AUGMENT® Injectable Bone Graft Company Completes Enrollment in UK-based Post-Market INFINITY™ Total Ankle System AMSTERDAM, The Netherlands, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) announced it will highlight new innovations at the American Orthopaedic Foot & A...
Wright Medical Group N.V. Reports 2019 Second Quarter Financial Results Second Quarter 2019 Net Sales, Including Cartiva®, of $230 Million, Representing As-Reported Growth of 12%, Constant Currency Growth of 13% and Organic Constant Currency Growth of 9% Second Quarter 2019 Net Loss From Continuing Operations of $19 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $35 Million, Representing Non-GAAP Adjusted EBITDA Margin of 15%, an Approximate 290 Basis Point Expansion Over Prior Year Quarter Company Updates 2019 Annual Guidance Reiterates Long-Term Financial Targets of Do...
Wright Medical Group N.V. to Present at Baird 2019 Global Healthcare Conference Wednesday, September 4, 2019 at 12:50 p.m. Eastern Time AMSTERDAM, The Netherlands, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) announced today that it will present at the Baird 2019 Global Healthcare Conference on Wednesday, September 4, 2019, at the InterContinental New York Barclay Hotel in New York. Julie Dewey, chief communications officer, will present at 12:50 p.m. Eastern Time. A live audio webcast of the conference presentation, along with the accompanying present...
Wright Medical Group N.V. to Present at 2019 Wells Fargo Healthcare Conference Thursday, September 5, 2019 at 9:10 a.m. Eastern Time AMSTERDAM, The Netherlands, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) announced today that it will present at the 2019 Wells Fargo Healthcare Conference on Thursday, September 5, 2019, at the Westin Copley Place Hotel in Boston. Robert Palmisano, president and chief executive officer, will present at 9:10 a.m. Eastern Time. A live audio webcast of the conference presentation, along with the accompanying presentation m...
Wright Medical Group N.V. to Host Second Quarter 2019 Earnings Conference Call Wednesday, August 7, 2019 at 3:30 p.m. Central / 4:30 p.m. Eastern AMSTERDAM, The Netherlands, July 16, 2019 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it will host a conference call on Wednesday, August 7, 2019, at 3:30 p.m. Central Time to discuss the company’s operating results for its second quarter ended June 30, 2019. Operating results will be released at 3:05 p.m. Central Time that day. The live dial-in number for the call is (844) 295-9436 (U.S.) / (574) 990-...
Wright Medical Group N.V. Reports 2019 First Quarter Financial Results First Quarter 2019 Net Sales, Including Cartiva®, of $230 Million, Representing As-Reported Growth of 16%, Constant Currency Growth of 18% and Organic Constant Currency Growth of 13% First Quarter 2019 Record Gross Margins of 80% First Quarter 2019 Net Loss From Continuing Operations of $30 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $37 Million, Representing Non-GAAP Adjusted EBITDA Margin of 16%, an Approximate 300 Basis Point Expansion Over Prior Year Quarter Company Reiterates 2019 Annual Guid...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.